Share:

Minimally Invasive Devices Market Size, Share & Trends Analysis Report By Product (Fully Automatic, Semi Automatic, Other), By Applications (Cardiothoracic, Orthopedic, Gastrointestinal, Gynecological, Urological, Vascular, Thoracic), By End Use, By Region, and Segment Forecasts - 2035

Last Updated: 16 August 2026
Base Year: 2025
Historical Data: 2021-2024
No of Pages: 126
  • The Minimally Invasive Devices Market is projected to reach USD 5866.18 Million by 2035, expanding at a steady pace during the forecast period. Market growth is supported by rising demand, technological advancements, and increasing adoption across major end-use industries worldwide.

  • What is the expected CAGR of the Minimally Invasive Devices Market during 2026-2035?

    The Minimally Invasive Devices Market is expected to grow at a CAGR of 4.65% during the forecast period from 2026 to 2035.

  • Which companies are leading the Minimally Invasive Devices Market?

    Key players in the Minimally Invasive Devices Market market include Ethicon (U.S.), Philips Healthcare (U.S.), Abbot Laboratories (U.S.), Smith & Nephew Plc (Europe), Boston Scientific (U.S.), Toshiba Medical Systems (Asia Pacific), Integrated Endoscopy (U.S.), Olympus Optical (Asia Pacific), Cooper Surgical (U.S.), Zimmer Biomet Holdings (U.S.), Hologic (U.S.), Medtronic (Europe), Hitachi High- Technologies Corporation (Asia Pacific), Intuitive Surgical (U.S.), Hill-Rom Holdings (U.S.), Stryker (U.S.), Getinge AB (Europe), Conmed Corp (U.S.)

  • How large was the Minimally Invasive Devices Market in 2025?

    The Minimally Invasive Devices Market was valued at USD 4891 Million in 2025, reflecting strong demand and continued adoption across major industries.

What is included in this Sample?

man icon
Mail icon
Captcha refresh